Literature DB >> 1697312

Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.

Y Fukuoka1, T E Hugli.   

Abstract

Incubation of radiolabeled human C3a with rat peritoneal mast cells resulted in high levels of uptake and extensive degradation of the ligand. Both cell-bound and free radiolabeled human C3a underwent extensive degradation by rat mast cells even at 0 degrees C. We examined several protease inhibitors for their ability to prevent degradation of radiolabeled human C3a by the rat mast cells. The inhibitors PMSF, chymostatin, and soybean trypsin inhibitor were most effective in preventing radiolabeled human C3a degradation. Degradation of the cell-bound ligand was totally inhibited only by PMSF. These compounds are effective inhibitors of a chymotrypsin-like enzyme (chymase) extracted from rat mast cells. Chemical cross-linking of radiolabeled human C3a to surface components on the rat mast cells, in the presence of PMSF, revealed one major and two minor bands. The mast cell component in both the major and minor bands proved to be chymase-associated based on a direct comparison with purified chymase isolated from rat mast cells. However, neither antichymase antibody nor chymase inhibitors influenced the degranulating activity of C3a on rat mast cells that occur independently of the C3a-chymase interactions. We conclude that there are neither specific C3a-binding sites on rat mast cells nor specific receptors whose occupancy leads to cellular activation. Although human C3ades Arg is inactive on guinea pig ileal and lung tissue, it binds to and induces degranulation of rat mast cells, as well as enhances vascular permeability in rat skin, at concentrations nearly identical to that of intact C3a. The fact that both C3a and C3ades Arg stimulated mast cell activation, at concentrations in excess of 10(-6) M, argues against specific binding sites for the anaphylatoxin on rat mast cells. It is proposed that the cationic C3a molecule activates rat mast cells in a secretory and nonlytic manner by a nonspecific mechanism similar to that of other polybasic compounds.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1697312

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

Authors:  Katerina Oikonomopoulou; Robert A DeAngelis; Hui Chen; Eleftherios P Diamandis; Morley D Hollenberg; Daniel Ricklin; John D Lambris
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

2.  Functional activities of synthetic anaphylatoxic peptides in widely used biological assays.

Authors:  A Kola; A Klos; W Bautsch; T Kretzschmar; J Köhl
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 3.  A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients.

Authors:  M Z Ratajczak; C H Kim; A Abdel-Latif; G Schneider; M Kucia; A J Morris; M J Laughlin; J Ratajczak
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

4.  Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activation of rat peritoneal mast cells by C3ades Arg.

Authors:  T Kajita; T E Hugli
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

5.  G protein coupled receptor specificity for C3a and compound 48/80-induced degranulation in human mast cells: roles of Mas-related genes MrgX1 and MrgX2.

Authors:  Sakeen W Kashem; Hariharan Subramanian; Sarah J Collington; Paola Magotti; John D Lambris; Hydar Ali
Journal:  Eur J Pharmacol       Date:  2011-07-03       Impact factor: 4.432

6.  A blockade of complement activation prevents rapid intestinal ischaemia-reperfusion injury by modulating mucosal mast cell degranulation in rats.

Authors:  T Kimura; A Andoh; Y Fujiyama; T Saotome; T Bamba
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

7.  Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin.

Authors:  J A Ember; S D Sanderson; T E Hugli; E L Morgan
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

Review 8.  The role of mast cells in ischemia and reperfusion injury.

Authors:  Mu-qing Yang; Yuan-yuan Ma; Jing Ding; Ji-yu Li
Journal:  Inflamm Res       Date:  2014-08-10       Impact factor: 4.575

9.  Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.

Authors:  M Oppermann; O Götze
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

10.  Impaired mobilization of hematopoietic stem/progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes.

Authors:  H M Lee; W Wu; M Wysoczynski; R Liu; E K Zuba-Surma; M Kucia; J Ratajczak; M Z Ratajczak
Journal:  Leukemia       Date:  2009-08-06       Impact factor: 11.528

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.